High-content behavioral phenotyping of model organisms in three dimensions with a gigapixel microscope
Award amount
$1,996,374Program and phase
SBIR · Phase IIAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- RAMONA OPTICS INC
- Proposal award date
- 2024-05-15
- Contract end date
- 2026-04-30
- UEI
- MR4ZCJJQHHP5
- Solicitation number
- PA22-176
- Topic code
- 100
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Rapid inter-procedural 3D scanning of fine-needle aspiration cytology slides with a parallelized microscope
- A parallelized computational microscope platform for high-throughput live imaging of patient-derived organoids
- Integrating developmental neurotoxicity screening using automated neuro-behavioral, morphological and neuro-developmental tests in the larval zebrafish
- A parallelized imaging platform for accurate and efficient long-term assessment of brain organoid development
- Rapid 3D Whole-Slide Digitization of Thick Cytopathology Slides with a Gigapixel Microscope
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- First-in-class TREM-1 inhibitors for neovascular retinal diseases
- Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
- Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
- Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing
Research funding history
12 SBIR/STTR records share this UEI (2017–2025). Reported award amounts total $11,552,328. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation